A Phase 1, Open-Label, Randomized Study to Investigate the Pharmacokinetics and Safety of Multiple Doses of Intranasal Naloxone in Healthy Participants. [PDF]
Cassie D +4 more
europepmc +1 more source
Kratom Toxicity: Pharmacologic Mechanisms, Clinical Risks, and Management Considerations. [PDF]
Babun AA +6 more
europepmc +1 more source
Drug and Alcohol Review, Volume 45, Issue 6, September 2026.
Thileepan Naren +8 more
wiley +1 more source
A Fentanyl-Responsive Microneedle Patch for Harm Reduction. [PDF]
Zhao P +10 more
europepmc +1 more source
<b>The RESPONDER trial:</b> a feasibility study of an early intervention model deploying community first responders to administer intranasal naloxone in suspected opioid overdoses in Skåne, Sweden. [PDF]
Rehn J +9 more
europepmc +1 more source
Evaluation of Intravenous Lipid Emulsion as an Adjunctive Antidote in Experimental Fentanyl Toxicity: Comparison with Naloxone in a Rat Model. [PDF]
Kehayova G +9 more
europepmc +1 more source
Pain relief but respiratory depression: Insights into the dark side of opioid overuse
The Journal of Physiology, Volume 604, Issue 17, Page 7017-7018, 1 September 2026.
Daniel B. Zoccal
wiley +1 more source
Methadone vs Buprenorphine-Naloxone in Opioid Overdose Survivors.
Kleinman RA +5 more
europepmc +1 more source
Implementation of mobile medical units for naloxone distribution and MOUD linkage in Ohio's HEALing Communities Study: a community case study. [PDF]
Rubi S +6 more
europepmc +1 more source

